{
    "ticker": "RXRX",
    "name": "Recursion Pharmaceuticals, Inc.",
    "description": "Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technologies, including artificial intelligence and machine learning, to accelerate drug discovery and development. Founded in 2013, the company focuses on mapping the biology of disease in order to identify new therapies for a variety of health conditions. Recursion's unique platform integrates experimental biology with high-throughput imaging, allowing for the analysis of cellular responses at an unprecedented scale. The company aims to transform the traditional pharmaceutical development process by combining data science with biology to discover and develop treatments for conditions such as cancer, rare diseases, and neurodegenerative disorders. With a commitment to innovation and a collaborative approach, Recursion seeks to create a new standard for drug development, ultimately improving patient outcomes and advancing healthcare. Their mission is to redefine how drugs are discovered, making the process faster, more efficient, and more effective.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Salt Lake City, Utah, USA",
    "founded": "2013",
    "website": "https://www.recursionpharma.com",
    "ceo": "Chris Gibson",
    "social_media": {
        "twitter": "https://twitter.com/RecursionPharma",
        "linkedin": "https://www.linkedin.com/company/recursionpharmaceuticals/"
    },
    "investor_relations": "https://investors.recursionpharma.com",
    "key_executives": [
        {
            "name": "Chris Gibson",
            "position": "CEO"
        },
        {
            "name": "Erin G. M. O'Reilly",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Drug Development Platforms",
            "products": [
                "Recursion's AI Platform",
                "High-Throughput Imaging"
            ]
        },
        {
            "category": "Therapeutics",
            "products": [
                "Therapies for Cancer",
                "Neurodegenerative Diseases"
            ]
        }
    ],
    "seo": {
        "meta_title": "Recursion Pharmaceuticals, Inc. | AI-Driven Drug Discovery",
        "meta_description": "Explore Recursion Pharmaceuticals, Inc., a leader in AI-driven drug discovery. Learn about their innovative platforms and commitment to transforming healthcare.",
        "keywords": [
            "Recursion",
            "AI Drug Discovery",
            "Biotechnology",
            "Pharmaceuticals",
            "Chris Gibson"
        ]
    },
    "faq": [
        {
            "question": "What does Recursion Pharmaceuticals do?",
            "answer": "Recursion Pharmaceuticals uses AI and machine learning to accelerate drug discovery and development."
        },
        {
            "question": "Who is the CEO of Recursion Pharmaceuticals?",
            "answer": "Chris Gibson is the CEO of Recursion Pharmaceuticals, Inc."
        },
        {
            "question": "Where is Recursion Pharmaceuticals headquartered?",
            "answer": "Recursion Pharmaceuticals is headquartered in Salt Lake City, Utah, USA."
        },
        {
            "question": "What are Recursion's main products?",
            "answer": "Recursion's main products include its AI platform for drug discovery and various therapeutics for diseases such as cancer and neurodegenerative disorders."
        },
        {
            "question": "When was Recursion Pharmaceuticals founded?",
            "answer": "Recursion Pharmaceuticals was founded in 2013."
        }
    ],
    "competitors": [
        "CRSP",
        "EDIT",
        "NVTA",
        "SGEN"
    ],
    "related_stocks": [
        "AMGN",
        "BIIB",
        "RHHBY",
        "VRTX"
    ]
}